Does antithrombotic therapy improve survival with colorectal cancer?
Abstract Background The study aimed to evaluate the prognosis for patients with colorectal cancer who underwent surgery while receiving antithrombotic therapy (ATT) across all disease stages and for patients at disease stages 0–III. Methods This retrospective cohort study included 710 Japanese patie...
Main Authors: | Kodai Takahashi, Hideto Ito, Masatoshi Hashimoto, Kazuhito Mita, Hideki Asakawa, Takashi Hayashi, Keiichi Fujino |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12957-017-1235-z |
Similar Items
-
Intelligent antithrombotic nanomedicines: Progress, opportunities, and challenges
by: Junchao Xu, et al.
Published: (2021-04-01) -
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
by: Abdelmoniem Moustafa, et al.
Published: (2019-10-01) -
Is breast cancer surgery safely performed in patients receiving antithrombotic therapy?
by: Emoto Norio, et al.
Published: (2017-03-01) -
Clinical Outcome in Patients With Intracerebral Hemorrhage Stratified by Type of Antithrombotic Therapy
by: Merih Irem Baharoglu, et al.
Published: (2021-06-01) -
Impact of Preinjury Antithrombotic Therapy on 30–Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)
by: Pål Rønning, et al.
Published: (2021-05-01)